| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/26/2005 | EP1500654A1 Benzoxazinone derivatives, the preparation and use thereof as medicaments |
| 01/26/2005 | EP1500648A1 Novel piperidine derivative |
| 01/26/2005 | EP1500403A1 Preventive/remedy for diabetes |
| 01/26/2005 | EP1500402A1 Cell death inhibitor |
| 01/26/2005 | EP1499742A1 Nad)p)h oxidase inhibitors for increased glucose uptake and treatment of type ii diabetes |
| 01/26/2005 | EP1499721A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription factors |
| 01/26/2005 | EP1499631A2 Rna interference mediated inhibition of tgf-beta and tgf-beta receptor gene expression using short interfering nucleic acid (sina) |
| 01/26/2005 | EP1499605A2 NF-KappaB INHIBITORS |
| 01/26/2005 | EP1499601A1 New 2-substituted -1,3-thiazole compounds |
| 01/26/2005 | EP1499600A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 01/26/2005 | EP1499599A1 Substituted pyrazine derivatives |
| 01/26/2005 | EP1499588A1 Melanocortin receptor ligands |
| 01/26/2005 | EP1499586A1 Novel form of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine |
| 01/26/2005 | EP1499580A1 Compounds that stimulate glucose utilization and methods of use |
| 01/26/2005 | EP1499578A2 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 01/26/2005 | EP1499358A1 Ph-sensitive polymer |
| 01/26/2005 | EP1499357A1 Treatment of metabolic syndrome |
| 01/26/2005 | EP1499352A1 Recombinant anti-interleukin-9 antibodies |
| 01/26/2005 | EP1499345A2 Protein a compositions and methods of use |
| 01/26/2005 | EP1499340A2 Proteins involved in the regulation of energy homeostasis |
| 01/26/2005 | EP1499338A1 7-hydroxy-16alpha-fluoro-5-androsten-17-ones and 7-hydroxy-16alpha-fluoro-5-androstan-17-ones and derivatives thereof |
| 01/26/2005 | EP1499336A2 Protease inhibitors |
| 01/26/2005 | EP1499330A1 Arsenic therapy for apls-type autoimmune lymph-oproliferative syndrome in mice and humans |
| 01/26/2005 | EP1499324A1 Method for treating and preventing hyperparathyroidism |
| 01/26/2005 | EP1499322A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 01/26/2005 | EP1499320A1 Novel compounds |
| 01/26/2005 | EP1499317A1 Treatment of diabetes and diabetic complications with nhe-1 inhibitors |
| 01/26/2005 | EP1499316A1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists |
| 01/26/2005 | EP1499314A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders |
| 01/26/2005 | EP1499306A2 Bicyclic amides |
| 01/26/2005 | EP1499297A2 Pharmaceutical formulation comprising atorvastatin calcium |
| 01/26/2005 | EP1499294A2 Transport system in biological systems |
| 01/26/2005 | EP1499277A2 Modification of feeding behavior |
| 01/26/2005 | EP1499206A1 Hydrothermically processed compositions containing phytosterols |
| 01/26/2005 | EP1499204A2 Physiologically compatible, phospholipid-containing, stable and hard matrix |
| 01/26/2005 | EP1406610B1 Use of substituted gamma-lactone compounds as medicaments |
| 01/26/2005 | EP1385881A4 Anti-obesity polypeptides |
| 01/26/2005 | EP1370564B1 Resveratrol-phospholipids complexes |
| 01/26/2005 | EP1301514B1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/26/2005 | EP1296976B1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them |
| 01/26/2005 | EP1278749B1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO 3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 01/26/2005 | EP1265942B1 Use of poly(diallylamine) polymers |
| 01/26/2005 | EP1084109B1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 01/26/2005 | EP0994655B1 Satiety product |
| 01/26/2005 | EP0944592B1 Vitamin d3 derivatives |
| 01/26/2005 | EP0914110B1 Method of modulating microcirculation |
| 01/26/2005 | EP0866691B2 Sublingual and buccal administration of selegiline |
| 01/26/2005 | EP0579758B1 Parathyroid hormone receptor and dna encoding same |
| 01/26/2005 | CN1571796A Melanocortin receptor ligands |
| 01/26/2005 | CN1571794A Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 01/26/2005 | CN1571793A Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same |
| 01/26/2005 | CN1571781A 4-imidazolin-2-one compounds |
| 01/26/2005 | CN1571774A Pyrimidinones as melanin concentrating hormone receptor 1 |
| 01/26/2005 | CN1571769A Process for the preparation of repaglinide |
| 01/26/2005 | CN1571766A Novel compounds, their preparation and use |
| 01/26/2005 | CN1571676A Biphasic mixtures of GLP-1 and insulin |
| 01/26/2005 | CN1571675A Treatment and diagnosis of insulin-resistant states |
| 01/26/2005 | CN1571674A Use of histamine to treat liver disease |
| 01/26/2005 | CN1571672A Administration of estradiol metabolites for the treatment or prevention of obesity, metabolic syndrome, diabetes, and vascular and renal disorders |
| 01/26/2005 | CN1571668A Salts formed of an AT1-receptor antagonist and a cardiovascular agent |
| 01/26/2005 | CN1571667A Inhibitors of dipeptidyl peptidase ó¶ |
| 01/26/2005 | CN1571665A Substituted N-phenyl 2-hydroxy-2-methyl-3, 3, 3-trifluropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 01/26/2005 | CN1571662A Highly compressible ethylcellulose for tableting |
| 01/26/2005 | CN1571637A Use of cystathionine |
| 01/26/2005 | CN1570077A Grifola frondosa mycelia moisture method ultramicro wall break method |
| 01/26/2005 | CN1569884A Method for preparing astragaloside and its use in preparation of drug for preventing and treating diabetic nephropathy |
| 01/26/2005 | CN1569868A Pineapple flavonoid glycoside compound and its use |
| 01/26/2005 | CN1569867A Preparation method and use of skunk bush extract morroniside |
| 01/26/2005 | CN1569834A Benzyloxy substituted indole compound and its analog and their production method and application |
| 01/26/2005 | CN1569777A Chiral source and pharmaceutical salt or complex of organic alkali drug |
| 01/26/2005 | CN1569236A Implantable pouch seeded with insulin-producing cells to treat diabetes |
| 01/26/2005 | CN1569216A Nanometer natural biological protein bee product and its preparation |
| 01/26/2005 | CN1569180A Medicine for treating diabetes and its vascular complications and preparation method thereof |
| 01/26/2005 | CN1569167A Method for extracting Vitamin B from wheat bran |
| 01/26/2005 | CN1569138A Preparation method of arctium fruit extract for decreasing blood sugar |
| 01/26/2005 | CN1569120A Effective portion extraction of dogwood and its preparation method and usage |
| 01/26/2005 | CN1569119A Dogwood extraction and its preparation method and usage |
| 01/26/2005 | CN1569115A Healthy product for preventing and treating cardiovascular and cerebrovascular disease |
| 01/26/2005 | CN1569109A Preparation method of an arteria coronaria dialating and blood fat reducing Chinese medicine- |
| 01/26/2005 | CN1569101A Pure Chinese medicinal preparation for treating diabetes |
| 01/26/2005 | CN1569067A Usage of rhubarb root and its extractions in the process for preparing postprandial blood sugar decreasing medicine |
| 01/26/2005 | CN1569064A Novel use of bighead atractylodes rhizome in pharmacy |
| 01/26/2005 | CN1569058A Innovative technique for processing aloe raw material with high stability |
| 01/26/2005 | CN1569054A Dripping pills of 'Xiao Chaihu' |
| 01/26/2005 | CN1569035A Manufacturing method of biological protein calcium with metal sulfur protein |
| 01/26/2005 | CN1569007A Amino acid liquor and its preparation method |
| 01/26/2005 | CN1568993A Composition for treating hyperlipemia |
| 01/26/2005 | CN1568988A Oral compound pharmaceutical formulation for decreasing blood sugar |
| 01/26/2005 | CN1568976A Application of bendazac lysine in the preparing process of medicine for preventing and treating diabetic nephropathy |
| 01/26/2005 | CN1568969A Preparing method and usage of vitamin E clathrate |
| 01/26/2005 | CN1568958A Unsaturated fatty acid formula products with high content of alpha and gamma linolenic acid and preparation method threreof |
| 01/26/2005 | CN1568957A Reforming effect of arginine to recessive harm of skin tissue of diabetic |
| 01/26/2005 | CN1568952A Peroral blood sugar reducing compound pharmaceutical preparation |
| 01/26/2005 | CN1568950A Dimethyl biguanide sustained release capsule and preparation method thereof |
| 01/26/2005 | CN1568803A Food with blood-sugar/blood-fat reducing function and preparation method thereof |
| 01/26/2005 | CN1186351C Total saponin of polygara aureocauda dunn and its pharmaceutical composition and preparing method |
| 01/26/2005 | CN1186335C Process for obtaining HMG-CoA reductase inhibitors of high purity |
| 01/26/2005 | CN1186332C New thryoid receptor ligands and process II |
| 01/26/2005 | CN1186322C Proline derivatives and use thereof as drugs |
| 01/26/2005 | CN1186315C O-anisamide derivatives |